|
Press Releases
| |
|
Displaying releases:
1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-100
|
| |
Aug-17-2010
|
Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men |
| |
Jun-25-2010
|
Palatin Technologies, Inc. To Raise $2.0 Million Dollars In Registered Direct Offering |
| |
Jun-24-2010
|
Palatin Technologies, Inc. Announces Last Patient Dosed And Database Lock In Subcutaneous Bremelanotide Trial In Men |
| |
Jun-21-2010
|
Palatin Technologies, Inc. Announces Positive Preclinical Data with PL-3994 for Asthma Indications
|
| |
May-13-2010
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on May 13, 2010
|
| |
May-13-2010
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on May 13, 2010
|
| |
May-11-2010
|
Palatin Technologies, Inc. To Report Fiscal Year 2010 Third Quarter Results;
Teleconference and Webcast to be held on May 13, 2010 |
| |
May-04-2010
|
Palatin Technologies, Inc. Issued U.S. Patent And
Receives Patent Allowance On Seven Additional Patents
|
| |
Mar-23-2010
|
Palatin Technologies, Inc. Receives $2.5 Million from Astrazeneca |
| |
Feb-25-2010
|
PALATIN TECHNOLOGIES, INC. TO RAISE $2.6 MILLION DOLLARS IN REGISTERED DIRECT OFFERING |
| |
Feb-16-2010
|
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on February 16, 2010 |
| |
Feb-09-2010
|
Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
|
| |
Dec-01-2009
|
Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate |
| |
Nov-16-2009
|
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009 |
| |
Nov-12-2009
|
Palatin Technologies, Inc. To Report Fiscal Year 2010 First Quarter Results;
Teleconference and Webcast to be held on November 16, 2009 |
| |
 |
|
|
